Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant long (Expand Search)
significant level » significance level (Expand Search), significance levels (Expand Search), significant gender (Expand Search)
Showing 3,421 - 3,440 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant linear) OR (significant level)) decrease ))', query time: 0.40s Refine Results
  1. 3421
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 3422
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3423
    Raw data.

    Raw data. by Changzhi Liu (518454)

    Published 2025
    “…The incidence of fractures was significantly greater among participants with low RC levels than among those with high RC levels (6.4% vs. 3.1%, P < 0.01). …”
    Save to List
    Saved in:
  4. 3424
    Baseline characteristics of the subjects.

    Baseline characteristics of the subjects. by Changzhi Liu (518454)

    Published 2025
    “…The incidence of fractures was significantly greater among participants with low RC levels than among those with high RC levels (6.4% vs. 3.1%, P < 0.01). …”
    Save to List
    Saved in:
  5. 3425
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  6. 3426
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 3427
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 3428
    The ANCOVA and Post_hoc results.

    The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 3429
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 3430
    CONSORT flowchart.

    CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 3431
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 3432
    Indications for warfarin prescription in outpatients and inpatients in 2023.

    Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 3433
    Time to stabilization in the mediolateral direction.

    Time to stabilization in the mediolateral direction. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 3434
    Western blotting for OMP expression using olfactory bulb and olfactory epithelium.

    Western blotting for OMP expression using olfactory bulb and olfactory epithelium. by Myeongguk Jeong (16386165)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 3435
    Outpatient utilization of anticoagulants from 2019 to 2023.

    Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 3436
    Participant’s data including characteristics and primary outcome measurement.

    Participant’s data including characteristics and primary outcome measurement. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 3437
    Olfactory function test graphical summary and results.

    Olfactory function test graphical summary and results. by Myeongguk Jeong (16386165)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 3438
    Time to stabilization in the vertical direction.

    Time to stabilization in the vertical direction. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 3439
    Utilization of anticoagulants from 2019 to 2023.

    Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 3440
    The description of games.

    The description of games. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: